Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2021-02-26 Delisting Announcement
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
First Day of Dealings
Delisting Announcement Classification · 99% confidence The document is identified by the RNS Number (4260Q) and explicitly states it is a 'Press Release' from 'Cellular Goods PLC' dated February 26, 2021. The content details the 'First day of dealings' and 'Admission to the Official List' following a significantly oversubscribed Initial Public Offering (IPO) that raised £13 million. This announcement concerns the company's listing and capital structure change (issuance of shares for public trading). While it relates to capital (CAP), the primary nature of this specific RNS release is announcing the successful completion of the IPO and the commencement of trading, which is a significant regulatory event often categorized broadly. Since it announces the issuance of shares and the resulting capital structure change, 'Share Issue/Capital Change' (SHA) is a strong candidate. However, the document is a general regulatory announcement provided via RNS, which is the service distributing it. Given the context of an IPO completion and listing announcement, which is a specific type of regulatory disclosure, and the presence of the RNS header and footer, it fits well under the general 'Regulatory Filings' (RNS) category if a more specific code like CAP or SHA is not deemed a perfect fit for the *announcement* itself. Since the core event is the admission to the market following a share issuance, SHA is highly relevant. Let's re-evaluate the definitions: SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' This IPO announcement is fundamentally about a new share issue and capital change. Therefore, SHA is the most precise fit over the general RNS fallback.
2021-02-26 English
Cellular Goods plc - Single prospectus
Capital/Financing Update Classification · 95% confidence The document is a formal 'Prospectus' for Cellular Goods PLC, detailing a conditional placing of shares, admission to the Official List, and trading on the London Stock Exchange. It contains comprehensive sections on risk factors, financial information, and corporate governance, which are characteristic of a regulatory document required for a public offering. While it is not a standard 10-K, it falls under the category of a regulatory filing for capital raising and listing, which is best classified as a 'Regulatory Filing' (RNS) in the absence of a specific 'Prospectus' category, as it is a formal regulatory document filed with the FCA.
2021-02-23 English
£13 million raised in Initial Public Offering
Share Issue/Capital Change Classification · 99% confidence The document is identified by the RNS Number (0363Q) and the header indicating it is a 'Press Release' from 'Cellular Goods PLC' dated February 23, 2021. The content explicitly announces the successful raising of £13 million in an Initial Public Offering (IPO), details the share allocation, mentions the publication of the prospectus, and provides an expected trading commencement date. This is a significant corporate action announcement related to fundraising and listing. While it mentions the 'Publication of prospectus', the core content is the announcement of the capital raising success. This type of announcement, especially one detailing fundraising proceeds and listing details, fits best under 'Capital/Financing Update' (CAP). It is not a full 10-K, an ER (which is usually quarterly results), or a simple RPA, as it contains substantial details about the financing terms and success.
2021-02-23 English
Full accounts made up to 2020-08-31
Regulatory Filings
2021-02-16 English
Intention to Float on the LSE
Share Issue/Capital Change Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content announces the 'Intention to Float on the London Stock Exchange' (IPO intentions), which is a significant corporate action announcement. While it discusses future financial events (the prospectus), the document itself is a press release format announcing the intention and providing details about the company, management, and advisers. This type of general, time-sensitive corporate announcement that is distributed via the official regulatory news service (RNS) and does not fit neatly into specific financial report categories (like 10-K, ER, or IR) is best classified as a Regulatory Filing (RNS), which serves as the general regulatory announcement category.
2021-02-04 English
Full accounts made up to 2019-08-31
Regulatory Filings
2020-03-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.